This page lists all pharmaceutical reports related to the field of Pain. The reports include market research reports and pipeline analyses.
- The World Market for Pain Management Drugs and Devices
- The Global Market for Adjunctive Therapies in Cancer
- The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products
- Diabetes and Diabetic Complications: Major World Markets
- Cancer Therapeutics: The Worldwide Market
- Pain Therapeutics - Drugs, Markets and Companies
- Personalized Medicine - scientific and commercial aspects
- Nitric Oxide - Therapeutics, Markets and Companies
- Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
- Cannabinoid Market Forecasts & Analysis to 2012
- Early Toxicology: Markets and Approaches
- Osteoarthritis - Market sees steady growth
- Migraine - Innovation essential as weak late-stage pipeline fails to hold off the impact of triptan patent expiries
- Breakthrough Pain - Fast-acting players will capture majority market share
- Osteoarthritis - The Wait for a DMOAD Continues
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Neuropathic Pain - A Plethora of Patient Segmentation and Product Differentiation Opportunities
- From Blockbuster to Nichebuster
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- Pain Therapeutics 2005
- Therapeutic Vaccines
- Orthopedic Postoperative Pain
- Pipeline Insight: Neuropathic Pain
- Endo Pharmaceuticals’ Lidoderm - Physician survey indicates increased use likely to fuel sales
- Anesthesia Drugs: Worldwide Markets
- Stakeholder Opinions: Fibromyalgia - Potentially lucrative market soon to become reality
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Irritable Bowel Syndrome - A potentially profitable market with limited competition
- Drug Discovery Tools for High-Content Analysis
- HEADACHE - Therapy Area Pipeline Report
- MIGRAINE - Therapy Area Pipeline Report
- NEUROPATHY - Therapy Area Pipeline Report
- PAIN - Therapy Area Pipeline Report
- DENTAL PAIN - Therapy Area Pipeline Report
- IRRITABLE BOWEL SYNDROME (IBS) - Therapy Area Pipeline Report
- MUSCLE PAIN - Therapy Area Pipeline Report
- DIABETIC NEUROPATHY - Therapy Area Pipeline Report
- Peripheral Neuropathy and Neuropathic Pain, 2008
- Commercial Insight: Migraine - Opportunities will exist in the wake of generic attack
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Translational Medicine in Biopharmaceutical Research and Development
- The CNS Market Outlook
- The Gastrointestinal Market Outlook to 2012
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Coxibs - Past Problems and Future Potential
- Postoperative Pain: Dynastat Cutting Up The Pain Market
- Treatment Algorithms: Cancer Pain - Physician Awareness and Novel Drug Delivery
- Neuropathic Pain Insight - Life Beyond Gabapentin
- Stakeholder Insight: Osteoarthritis - COX-2s wear down traditional NSAID use
- Stakeholder Insight: Neuropathic Pain - Treatment Preferences Across the 7 Major Markets
- Stakeholder Insight: Fibromyalgia - Substantial Growth Opportunity for SNRI Antidepressants
- Stakeholder Insight: Diabetic Neuropathic Pain - Market Success is Not Limited to Pregabalin
- Stakeholder Insight: HIV Related Neuropathic Pain - Useful Niche for Peripheral Companies
- Stakeholder Insight: Neuropathic Low Back Pain - Off-label Revenue Despite Diagnostic Challenge
- Commercial Insight: Migraine - A Painful Future for the Triptans?
- Stakeholder Opinions: Migraine - Lots of Experience, But Less Expertise
- Innovations in CNS: Novel therapeutics and future R&D strategies
- The World Market for Pain Management Drugs and Devices: Applications and Top Products
- The U.S. Market for Over-the-Counter Pain Medication
- Gene Expression Profiling Markets
- UpdatesPlus-Nicotinic Receptors (January 2008)
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Pipeline Insight: Neuropathic Pain - Emerging drugs fail to capitalize in lucrative market
- How to Conduct Clinical Trials in China
- The Anti-Migraine Market 2007-2022
- The Global Pain Pharmaceutical Market Analysis and Forecasts 2007-2022
- Nanotechnology: Revolutionizing R&D to develop smarter therapeutics and diagnostics
- The Pain Market Outlook to 2011
- UpdatesPlus-Nicotinic Receptors (February 2008)
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Neuronal Nicotinic Receptors: UpdatesPlus March 2008
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
- Commercial and Pipeline Insight: Opioids - Short acting and anti-abuse technologies set to fragment
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- CNS Market Overview - neurology, pain and psychiatry
- Neuronal Nicotinic Receptors - April 2008